Skip to search formSkip to main contentSkip to account menu

Cisatracurium

Known as: cisatracurium [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

9 relations
5 ML Cisatracurium 2 MG/ML Injection [Nimbex]Drug AllergyNeuromuscular Nondepolarizing Blockade [PE]analogs & derivatives

Narrower (3)

51W89Nimbexcisatracurium besylate

Broader (2)

AtracuriumNeuromuscular Blocking Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Anaphylaxis to cisatracurium following negative skin testing.
General anaesthesia for the patient with a history of anaesthesia-related anaphylaxis is challenging. Precautions against… 
2005
2005
Anaphylaxis to cisatracurium following negative skin testing.
General anaesthesia for the patient with a history of anaesthesia-related anaphylaxis is challenging. Precautions against… 
2004
2004
Comparison of Cisatracurium and Vecuronium by Infusion in Neonates and Small Infants after Congenital Heart Surgery
Background:Neonates and infants often require extended periods of mechanical ventilation facilitated by sedation and… 
Highly Cited
2003
Highly Cited
2003
Magnesium potentiates neuromuscular blockade with cisatracurium during cardiac surgery
PurposeMagnesium potentiates the effect of nondepoiarizing neuromuscular blocking agents. It is used in cardiac anesthesia to… 
Highly Cited
2003
Highly Cited
2003
A Mechanism for Rapacuronium-induced Bronchospasm: M2 Muscarinic Receptor Antagonism
Background A safe and effective ultra-short-acting nondepolarizing neuromuscular blocking agent is required to block nicotinic… 
Highly Cited
2002
Highly Cited
2002
A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients
Abstract Objectives. To compare two levels of continuous cisatracurium-induced curarization in hypoxemic, ventilated patients… 
1998
1998
Prolonged weakness after cisatracurium infusion: a case report.
OBJECTIVE To present the first documented case report of myopathy persisting for >48 hrs in a patient treated with cisatracurium… 
1998
1998
Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination
We compared the dose–response relationships of cisatracurium, mivacurium, atracurium, vecuronium and rocuronium and examined the… 
1998
1998
Pharmacokinetics and Pharmacodynamics of Cisatracurium After a Short Infusion in Patients Under Propofol Anesthesia
Fourteen patients, ASA physical status I or II, were recruited to assess the pharmacokinetic-pharmacodynamic relationship of… 
1997
1997
A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
OBJECTIVE To evaluate and compare the safety and efficacy of cisatracurium (51W89) and atracurium administered by continuous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)